(MedPage Today) — Janus kinase (JAK) inhibitors look to be a good treatment option for the newly recognized, rare autoimmune disease known as SOCS1 insufficiency, researchers found.
Which was not exactly a surprise. SOCS1 stands for “suppressor…
Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/114440
Author :
Publish date : 2025-02-28 21:11:07
Copyright for syndicated content belongs to the linked Source.
